Ernexa Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.38

-0.30 (-44.66%)

As of Feb 8, 2:34 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +8,077.0% upside

Low Target $21.48

Average Target $30.77

High Target $35.71

Current Price $0.38

Current
$0.38

Target
$30.77

$21.48 $30.77 avg $35.71

Scenario Analysis

Bear Case

$21.48

5,608.2%

Low target

Base Case

$30.77

+8,077.0%

Avg target

Bull Case

$35.71

+9,389.8%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$32.22

-98.8% from high

52-Week Low

$16.66

+-97.7% from low

Target vs 52W High

$30.77

-4.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%